Standard Lithium Declines Following $120M Public Offering of Common Shares
Stock Performance: Standard Lithium's stock dropped 16.8% in post-market trading after announcing a public offering of $120 million in common shares.
Use of Proceeds: The company plans to use the proceeds from the offering for capital expenditures on its South West Arkansas and Franklin projects, as well as for working capital and general corporate purposes.
Trade with 70% Backtested Accuracy
Analyst Views on SLI
About SLI
About the author
China Lithium Prices Surge 9% as Export Tax Rebates Adjust
- Policy Impact: China's Ministry of Finance announced a complete rollback of VAT export rebates for battery products starting January 1, 2027, which is expected to prompt exporters to accelerate overseas shipments, thereby increasing lithium demand and driving prices higher.
- Lithium Price Surge: The most-active lithium carbonate contract on the Guangzhou Futures Exchange closed up 9% at 156,060 yuan/metric ton, marking the highest level since November 2023, reflecting optimistic market expectations for future lithium demand.
- Positive Market Reaction: In pre-market U.S. trading, lithium miners saw significant stock price increases, with Albemarle up 1.7%, SQM up 4.2%, and Lithium Americas up 5.2%, indicating investor confidence in the lithium market outlook.
- Battery Production Boost: Analysts noted that the anticipated short-term increase in battery production will further drive lithium demand, especially as exporters rush to ship batteries ahead of the tax policy changes, enhancing the market position of lithium miners.
Reasons Behind Today's Surge in Standard Lithium Stock
China's License Cancellations: China is set to cancel 27 lithium mining licenses, primarily for non-operational mines, which has led to a spike in lithium prices and increased interest in global lithium stocks.
Market Reaction: Following the announcement, lithium prices in China rose by approximately 7.6%, positively impacting shares of companies like Standard Lithium, which saw a more than 6% increase in early trading.
Analyst Perspective: Analysts believe the cancellations will have minimal impact on lithium supply since the revoked permits were for non-operating mines, but the potential for future supply increases has investors optimistic about price rises.
Investment Caution: Despite the excitement around lithium stocks, Standard Lithium has yet to generate revenue and is projected to remain unprofitable until at least 2028, leading to caution among investors regarding its stock viability.
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
Standard Lithium Joint Venture Draws Over $1 Billion in Funding Interest for Arkansas Initiative
Financing Interest: Standard Lithium's Smackover Lithium joint venture with Equinor has received over $1 billion in financing interest for its South West Arkansas project, with three export credit agencies expressing interest in providing debt financing.
Debt Financing Details: The joint venture is seeking up to $1.1 billion in senior secured debt financing to cover most of the $1.45 billion cost for the first phase of the project, which includes a financing package from export credit agencies and commercial banks.
Project Ownership: Standard Lithium owns 55% of the Smackover Lithium joint venture and is responsible for operating the projects, while Equinor holds the remaining 45%.
Government Support: Earlier this year, the project received a $225 million grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
Major Stocks Including Elastic, Veeva Systems, and HIVE Digital Decline in Friday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures rose this morning, with Dow futures increasing by approximately 200 points on Friday.
Elastic NV Earnings Report: Elastic NV's shares dropped 12.3% in pre-market trading despite reporting adjusted earnings of 64 cents per share, surpassing analyst expectations, and quarterly revenue of $423.48 million, which also exceeded estimates.
Other Stocks Declining: Several other stocks experienced declines in pre-market trading, including Luda Technology Group Ltd (-11.1%), AnaptysBio Inc (-9.7%), and Sigma Lithium Corp (-8.4%).
Veeva Systems Performance: Veeva Systems Inc saw a 6.7% drop in pre-market trading despite posting strong third-quarter results and raising its fiscal year earnings and revenue estimates above analyst predictions.
Roth Capital Reaffirms Buy Rating for Standard Lithium, Adjusts Price Target to $5.5
Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters, enhancing their trading strategies.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and resources.
Market Winning Tools: The platform is designed to provide traders with the tools they need to succeed in the markets every day.
China Lithium Prices Surge 9% as Export Tax Rebates Adjust
- Policy Impact: China's Ministry of Finance announced a complete rollback of VAT export rebates for battery products starting January 1, 2027, which is expected to prompt exporters to accelerate overseas shipments, thereby increasing lithium demand and driving prices higher.
- Lithium Price Surge: The most-active lithium carbonate contract on the Guangzhou Futures Exchange closed up 9% at 156,060 yuan/metric ton, marking the highest level since November 2023, reflecting optimistic market expectations for future lithium demand.
- Positive Market Reaction: In pre-market U.S. trading, lithium miners saw significant stock price increases, with Albemarle up 1.7%, SQM up 4.2%, and Lithium Americas up 5.2%, indicating investor confidence in the lithium market outlook.
- Battery Production Boost: Analysts noted that the anticipated short-term increase in battery production will further drive lithium demand, especially as exporters rush to ship batteries ahead of the tax policy changes, enhancing the market position of lithium miners.
Reasons Behind Today's Surge in Standard Lithium Stock
China's License Cancellations: China is set to cancel 27 lithium mining licenses, primarily for non-operational mines, which has led to a spike in lithium prices and increased interest in global lithium stocks.
Market Reaction: Following the announcement, lithium prices in China rose by approximately 7.6%, positively impacting shares of companies like Standard Lithium, which saw a more than 6% increase in early trading.
Analyst Perspective: Analysts believe the cancellations will have minimal impact on lithium supply since the revoked permits were for non-operating mines, but the potential for future supply increases has investors optimistic about price rises.
Investment Caution: Despite the excitement around lithium stocks, Standard Lithium has yet to generate revenue and is projected to remain unprofitable until at least 2028, leading to caution among investors regarding its stock viability.
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
Standard Lithium Joint Venture Draws Over $1 Billion in Funding Interest for Arkansas Initiative
Financing Interest: Standard Lithium's Smackover Lithium joint venture with Equinor has received over $1 billion in financing interest for its South West Arkansas project, with three export credit agencies expressing interest in providing debt financing.
Debt Financing Details: The joint venture is seeking up to $1.1 billion in senior secured debt financing to cover most of the $1.45 billion cost for the first phase of the project, which includes a financing package from export credit agencies and commercial banks.
Project Ownership: Standard Lithium owns 55% of the Smackover Lithium joint venture and is responsible for operating the projects, while Equinor holds the remaining 45%.
Government Support: Earlier this year, the project received a $225 million grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
Major Stocks Including Elastic, Veeva Systems, and HIVE Digital Decline in Friday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures rose this morning, with Dow futures increasing by approximately 200 points on Friday.
Elastic NV Earnings Report: Elastic NV's shares dropped 12.3% in pre-market trading despite reporting adjusted earnings of 64 cents per share, surpassing analyst expectations, and quarterly revenue of $423.48 million, which also exceeded estimates.
Other Stocks Declining: Several other stocks experienced declines in pre-market trading, including Luda Technology Group Ltd (-11.1%), AnaptysBio Inc (-9.7%), and Sigma Lithium Corp (-8.4%).
Veeva Systems Performance: Veeva Systems Inc saw a 6.7% drop in pre-market trading despite posting strong third-quarter results and raising its fiscal year earnings and revenue estimates above analyst predictions.
Roth Capital Reaffirms Buy Rating for Standard Lithium, Adjusts Price Target to $5.5
Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters, enhancing their trading strategies.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and resources.
Market Winning Tools: The platform is designed to provide traders with the tools they need to succeed in the markets every day.
